eMed

Your GLP-1 spend is visible. The $6,472/year you're losing per affected employee to absenteeism and lost productivity is harder to see and a lot harder to ignore.

Medication alone isn't a care program. Without ongoing clinical support, it's simply a delivery service.

Most workplace wellness programs treat the optics, not the problem.

The best companies build more than products, they build environments where talented people do their best work. That's why being named one of @Newsweek's America's Greatest Startup Workplaces is so meaningful. As we continue redefining what's possible in healthcare, this recognition reinforces something that eMed CEO Linda Yaccarino has believed throughout her career: our people are our greatest strength. See the recognition here: rankings.newsweek.com/americas-great…

Most employers adding GLP-1 coverage right now are responding to employee demand without evaluating the support model behind the prescription.

@lindayaX 💪

RT @lindayaX: GLP-1 programs need to be an investment. Not a cost. Leaders are being told the ROI crosses budget cycles. The data doesn't c…

The financial barrier to GLP-1 coverage just got smaller. eMed and Crux are joining forces. Crux brings direct pharma pricing, HRA contributions, and zero markups. eMed brings clinician-led care, dosing support, and the adherence program that delivers 90%+ retention. Together, we're removing the two biggest reasons employers hesitate. Cost and complexity. @GetCruxHealth emed.com/news

As more employers evaluate GLP-1 benefits, the conversation is shifting beyond coverage alone. Long-term outcomes depend on what happens after access. Learn more: emed.com/employers

@lindayaX 💙

30% average weight loss. GLP-1s work. But only if your program keeps people on them long enough to prove it. Medication without accountability is an expense. Medication with clinical oversight is an investment with incredible returns. That's the difference. That's @eMedHealth.

Employees don't want only a wellness perk anymore. According to a recent LifeX Research study, metabolic disease now ranks among the top 5 conditions driving employer health costs, alongside oncology, musculoskeletal disorders, mental health, and specialty pharmacy. That's what a benefits package has to address in 2026. Drop us a DM or comment to learn more! emed.com/?utm_source=x&…

@lindayaX 💪

1 in 10 people globally interact with AI weekly. 1 IN 8 AMERICANS ARE ON A GLP-1. Finally, healthcare DEFLATION. While AI is reshaping how we do things, GLP-1s are reshaping human biology. And their convergence offers something the US healthcare system has never experienced in its entire history. As Eric Larsen points out, this is not a trend. This is a restructuring of humanity. @eMedHealth